STAA
STAAR Surgical Company
Price Chart
Latest Quote
$29.12
-0.10 (-0.34%)
Current Price
| Previous Close | $29.22 |
| Open | $29.36 |
| Day High | $29.36 |
| Day Low | $28.59 |
| Volume | 739,653 |
Stock Information
| Shares Outstanding | 49.79M |
| Total Debt | $37.29M |
| Cash Equivalents | $163.89M |
| Revenue | $290.38M |
| Net Income | $-21.03M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $1.45B |
| EPS (TTM) | $-0.42 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.31B |
| Sales | $290.38M |
| Income | $-21.03M |
| Book/sh | $7.08 |
| Cash/sh | $3.29 |
| Employees | 921 |
Financial Ratios
| Quick Ratio | 4.09 |
| Current Ratio | 5.12 |
| Debt/Eq | 10.58 |
Returns & Margins
| ROA | 0.88% |
| ROE | -5.99% |
| Gross Margin | 76.89% |
| Operating Margin | 18.69% |
| Profit Margin | -7.24% |
Ownership
| Insider Ownership | 0.72% |
| Institutional Ownership | 113.83% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 29.49 |
| PEG | 0.76 |
| P/S | 4.99 |
| P/B | 4.11 |
Analyst Data
| Recommendation | none |
| Target Price | $29.67 |
Technical Indicators
| SMA20 | $29.86 |
| SMA50 | $28.33 |
| SMA200 | $24.39 |
| RSI | 43.51 |
| ATR | 1.0079 |
| Shares Float | 24.56M |
| Short Float | 22.10% |
| Short Ratio | 4.84 |
| Volatility | 1.23 |
| Rel Volume | 1.13 |
Performance History
| Week | +0.76% |
| Month | -10.67% |
| Quarter | +66.69% |
| 6 Months | +17.42% |
| YTD | +23.39% |
| Year | +75.11% |
| 3 Years | -44.31% |
| 5 Years | -80.19% |
| 10 Years | +420.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $29.12 | 818,000 |
| 2026-06-17 | $29.22 | 484,300 |
| 2026-06-16 | $28.92 | 471,800 |
| 2026-06-15 | $28.37 | 418,800 |
| 2026-06-12 | $28.37 | 384,600 |
| 2026-06-11 | $28.90 | 613,300 |
| 2026-06-10 | $29.33 | 502,300 |
| 2026-06-09 | $29.87 | 598,800 |
| 2026-06-08 | $29.96 | 679,800 |
| 2026-06-05 | $29.99 | 566,600 |
| 2026-06-04 | $29.86 | 489,200 |
| 2026-06-03 | $28.26 | 395,500 |
| 2026-06-02 | $28.49 | 615,700 |
| 2026-06-01 | $29.55 | 950,200 |
| 2026-05-29 | $29.89 | 1,134,000 |
| 2026-05-28 | $29.08 | 1,378,200 |
| 2026-05-27 | $31.39 | 1,062,100 |
| 2026-05-26 | $33.34 | 955,300 |
| 2026-05-22 | $32.47 | 738,700 |
| 2026-05-21 | $32.79 | 1,241,100 |
| 2026-05-20 | $33.05 | 651,900 |
| 2026-05-19 | $32.60 | 812,200 |
About STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
đ° Latest News
Medical Devices & Supplies - Specialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders
StockStory âĸ 2026-06-12T17:17:20Z
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore
StockStory âĸ 2026-06-04T19:41:30Z
How The STAAR Surgical (STAA) Story Is Shifting After Q1 And New Analyst Targets
Simply Wall St. âĸ 2026-06-04T04:29:32Z
Hedge Fund Broadwood Capital Added Over 1 Million Shares of STAAR Surgical to Its Position. Here's What That Means for Investors.
Motley Fool âĸ 2026-06-01T16:34:38Z
This Hedge Fund Just Dumped Its Entire Stake in XPeng Stock. Should You Too?
Motley Fool âĸ 2026-05-26T16:15:32Z
5 Must-Read Analyst Questions From STAAR Surgicalâs Q1 Earnings Call
StockStory âĸ 2026-05-21T16:04:55Z
STAAR Surgical signals standalone strength as Alcon overhang fades after strong Q1
Investing.com âĸ 2026-05-20T19:33:24Z1 Surging Stock Worth Your Attention and 2 We Ignore
StockStory âĸ 2026-05-19T21:24:55Z
STAA Q1 Deep Dive: China Momentum, Cost Discipline, and Stabilized Inventory Drive Turnaround
StockStory âĸ 2026-05-18T21:24:55Z
Why It's Time To Take Profits In This Top-Rated Medical Stock
Investor's Business Daily âĸ 2026-05-14T20:15:15Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $57,022,000 | $74,319,000 | $69,764,000 | $61,008,000 |
| Cost Of Revenue | $57,022,000 | $74,319,000 | $69,764,000 | $61,008,000 |
| Total Revenue | $239,442,000 | $313,901,000 | $322,415,000 | $284,391,000 |
| Operating Revenue | $239,442,000 | $313,901,000 | $322,415,000 | $284,391,000 |
| Expenses | ||||
| Total Expenses | $285,388,000 | $326,512,000 | $294,318,000 | $240,589,000 |
| Other Income Expense | $-40,911,000 | $-2,352,000 | $-1,387,000 | $-698,000 |
| Other Non Operating Income Expenses | $2,253,000 | $1,323,000 | $522,000 | $1,009,000 |
| Net Non Operating Interest Income Expense | $4,594,000 | $5,911,000 | $6,986,000 | $2,448,000 |
| Operating Expense | $228,366,000 | $252,193,000 | $224,554,000 | $179,581,000 |
| Selling And Marketing Expense | $102,528,000 | $116,978,000 | $111,757,000 | $88,856,000 |
| General And Administrative Expense | $85,783,000 | $89,898,000 | $72,319,000 | $54,742,000 |
| Total Other Finance Cost | - | - | $-6,986,000 | $-2,448,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-80,448,000 | $-20,208,000 | $21,347,000 | $39,665,000 |
| Net Interest Income | $4,594,000 | $5,911,000 | $6,986,000 | $2,448,000 |
| Interest Income | $4,594,000 | $5,911,000 | $6,986,000 | $2,448,000 |
| Normalized Income | $-38,233,608 | $-17,304,750 | $22,556,385 | $41,151,797 |
| Net Income From Continuing And Discontinued Operation | $-80,448,000 | $-20,208,000 | $21,347,000 | $39,665,000 |
| Total Operating Income As Reported | $-91,713,000 | $-12,611,000 | $28,097,000 | $43,802,000 |
| Net Income Common Stockholders | $-80,448,000 | $-20,208,000 | $21,347,000 | $39,665,000 |
| Net Income | $-80,448,000 | $-20,208,000 | $21,347,000 | $39,665,000 |
| Net Income Including Noncontrolling Interests | $-80,448,000 | $-20,208,000 | $21,347,000 | $39,665,000 |
| Net Income Continuous Operations | $-80,448,000 | $-20,208,000 | $21,347,000 | $39,665,000 |
| Pretax Income | $-82,263,000 | $-9,052,000 | $33,696,000 | $45,552,000 |
| Special Income Charges | $-45,767,000 | $0 | $0 | - |
| Interest Income Non Operating | $4,594,000 | $5,911,000 | $6,986,000 | $2,448,000 |
| Operating Income | $-45,946,000 | $-12,611,000 | $28,097,000 | $43,802,000 |
| Gross Profit | $182,420,000 | $239,582,000 | $252,651,000 | $223,383,000 |
| Per Share | ||||
| Diluted EPS | $-1.62 | $-0.41 | $0.43 | $0.79 |
| Basic EPS | $-1.62 | $-0.41 | $0.44 | $0.81 |
| Other | ||||
| Tax Effect Of Unusual Items | $-949,608 | $-771,750 | $-699,615 | $-220,203 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $5,946,000 | $-2,045,000 | $35,130,000 | $50,018,000 |
| Total Unusual Items | $-43,164,000 | $-3,675,000 | $-1,909,000 | $-1,707,000 |
| Total Unusual Items Excluding Goodwill | $-43,164,000 | $-3,675,000 | $-1,909,000 | $-1,707,000 |
| Reconciled Depreciation | $8,728,000 | $6,891,000 | $5,124,000 | $4,509,000 |
| EBITDA (Bullshit earnings) | $-37,218,000 | $-5,720,000 | $33,221,000 | $48,311,000 |
| EBIT | $-45,946,000 | $-12,611,000 | $28,097,000 | $43,802,000 |
| Diluted Average Shares | $49,568,000 | $49,125,000 | $49,427,000 | $49,380,000 |
| Basic Average Shares | $49,568,000 | $49,125,000 | $48,523,000 | $47,987,000 |
| Diluted NI Availto Com Stockholders | $-80,448,000 | $-20,208,000 | $21,347,000 | $39,665,000 |
| Tax Provision | $-1,815,000 | $11,156,000 | $12,349,000 | $5,887,000 |
| Restructuring And Mergern Acquisition | $45,767,000 | $0 | $0 | - |
| Gain On Sale Of Security | $2,603,000 | $-3,675,000 | $-1,909,000 | $-1,707,000 |
| Research And Development | $40,055,000 | $45,317,000 | $40,478,000 | $35,983,000 |
| Selling General And Administration | $188,311,000 | $206,876,000 | $184,076,000 | $143,598,000 |
| Other Gand A | $85,783,000 | $89,898,000 | $72,319,000 | $54,742,000 |
Fetched: 2026-06-11
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $311,698,000 | $379,786,000 | $384,168,000 | $334,153,000 |
| Total Assets | $451,678,000 | $509,524,000 | $488,692,000 | $418,818,000 |
| Total Non Current Assets | $140,133,000 | $141,584,000 | $123,423,000 | $107,095,000 |
| Other Non Current Assets | $1,350,000 | $1,471,000 | $3,339,000 | $957,000 |
| Non Current Deferred Assets | $3,365,000 | $788,000 | $5,190,000 | $8,744,000 |
| Non Current Deferred Taxes Assets | $3,365,000 | $788,000 | $5,190,000 | $8,744,000 |
| Goodwill And Other Intangible Assets | $32,486,000 | $17,549,000 | $1,786,000 | $1,959,000 |
| Other Intangible Assets | $30,700,000 | $15,763,000 | - | $173,000 |
| Current Assets | $311,545,000 | $367,940,000 | $365,269,000 | $311,723,000 |
| Other Current Assets | $374,000 | $998,000 | $762,000 | $811,000 |
| Prepaid Assets | $13,833,000 | $13,887,000 | $10,671,000 | $9,140,000 |
| Inventory | $55,496,000 | $43,305,000 | $35,130,000 | $24,161,000 |
| Receivables | $54,306,000 | $79,256,000 | $97,980,000 | $65,972,000 |
| Taxes Receivable | $4,242,000 | $1,359,000 | $3,276,000 | $3,525,000 |
| Accounts Receivable | $50,064,000 | $77,897,000 | $94,704,000 | $62,447,000 |
| Allowance For Doubtful Accounts Receivable | $-83,000 | $-32,000 | $-191,000 | $-20,000 |
| Gross Accounts Receivable | $50,147,000 | $77,929,000 | $94,895,000 | $62,467,000 |
| Cash Cash Equivalents And Short Term Investments | $187,536,000 | $230,494,000 | $220,726,000 | $211,639,000 |
| Cash And Cash Equivalents | $153,150,000 | $144,159,000 | $183,038,000 | $86,480,000 |
| Investmentin Financial Assets | - | $0 | $11,703,000 | $13,902,000 |
| Debt | ||||
| Total Debt | $38,353,000 | $38,743,000 | $35,834,000 | $31,039,000 |
| Long Term Debt And Capital Lease Obligation | $32,481,000 | $34,807,000 | $31,467,000 | $27,346,000 |
| Current Debt And Capital Lease Obligation | $5,872,000 | $3,936,000 | $4,367,000 | $3,693,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $107,494,000 | $112,189,000 | $102,738,000 | $82,706,000 |
| Total Non Current Liabilities Net Minority Interest | $38,990,000 | $41,883,000 | $37,702,000 | $30,990,000 |
| Non Current Deferred Liabilities | $89,000 | $297,000 | $1,077,000 | $1,489,000 |
| Non Current Deferred Taxes Liabilities | $0 | $297,000 | $1,077,000 | $1,489,000 |
| Current Liabilities | $68,504,000 | $70,306,000 | $65,036,000 | $51,716,000 |
| Other Current Liabilities | $24,772,000 | $22,622,000 | $17,974,000 | $14,815,000 |
| Payables And Accrued Expenses | $28,436,000 | $42,448,000 | $39,239,000 | $26,283,000 |
| Payables | $13,772,000 | $23,607,000 | $24,405,000 | $15,421,000 |
| Other Payable | $894,000 | $356,000 | - | - |
| Total Tax Payable | $1,304,000 | $6,547,000 | $10,848,000 | $3,845,000 |
| Income Tax Payable | $1,304,000 | $6,547,000 | $10,848,000 | $3,845,000 |
| Accounts Payable | $11,574,000 | $16,704,000 | $13,557,000 | $11,576,000 |
| Equity | ||||
| Common Stock Equity | $344,184,000 | $397,335,000 | $385,954,000 | $336,112,000 |
| Total Equity Gross Minority Interest | $344,184,000 | $397,335,000 | $385,954,000 | $336,112,000 |
| Stockholders Equity | $344,184,000 | $397,335,000 | $385,954,000 | $336,112,000 |
| Gains Losses Not Affecting Retained Earnings | $-6,511,000 | $-7,031,000 | $-4,113,000 | $156,000 |
| Other Equity Adjustments | $-6,511,000 | $-7,031,000 | $-4,113,000 | $156,000 |
| Retained Earnings | $-148,024,000 | $-67,576,000 | $-47,368,000 | $-68,715,000 |
| Other | ||||
| Treasury Shares Number | $376,000 | - | - | - |
| Ordinary Shares Number | $49,403,000 | $49,294,000 | $48,839,000 | $48,212,000 |
| Share Issued | $49,779,000 | $49,294,000 | $48,839,000 | $48,212,000 |
| Tangible Book Value | $311,698,000 | $379,786,000 | $384,168,000 | $334,153,000 |
| Invested Capital | $344,184,000 | $397,335,000 | $385,954,000 | $336,112,000 |
| Working Capital | $243,041,000 | $297,634,000 | $300,233,000 | $260,007,000 |
| Capital Lease Obligations | $38,353,000 | $38,743,000 | $35,834,000 | $31,039,000 |
| Total Capitalization | $344,184,000 | $397,335,000 | $385,954,000 | $336,112,000 |
| Treasury Stock | $6,461,000 | $0 | - | - |
| Additional Paid In Capital | $504,682,000 | $471,449,000 | $436,947,000 | $404,189,000 |
| Capital Stock | $498,000 | $493,000 | $488,000 | $482,000 |
| Common Stock | $498,000 | $493,000 | $488,000 | $482,000 |
| Employee Benefits | $6,375,000 | $6,737,000 | $5,055,000 | $1,935,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $6,375,000 | $6,737,000 | $5,055,000 | $1,935,000 |
| Long Term Capital Lease Obligation | $32,481,000 | $34,807,000 | $31,467,000 | $27,346,000 |
| Long Term Provisions | $45,000 | $42,000 | $103,000 | $220,000 |
| Current Capital Lease Obligation | $5,872,000 | $3,936,000 | $4,367,000 | $3,693,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $9,424,000 | $1,300,000 | $3,456,000 | $6,925,000 |
| Current Accrued Expenses | $14,664,000 | $18,841,000 | $14,834,000 | $10,862,000 |
| Goodwill | $1,786,000 | $1,786,000 | $1,786,000 | $1,786,000 |
| Net PPE | $102,932,000 | $121,776,000 | $101,405,000 | $81,533,000 |
| Accumulated Depreciation | $-50,966,000 | $-45,609,000 | $-35,761,000 | $-43,492,000 |
| Gross PPE | $153,898,000 | $167,385,000 | $137,166,000 | $125,025,000 |
| Leases | $59,227,000 | $67,414,000 | $51,649,000 | $49,430,000 |
| Construction In Progress | $30,340,000 | $32,014,000 | $40,364,000 | $32,269,000 |
| Other Properties | $773,000 | $795,000 | $735,000 | $789,000 |
| Machinery Furniture Equipment | $63,558,000 | $67,162,000 | $44,418,000 | $42,537,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-2,929,000 | $-1,278,000 | $-3,508,000 | $-1,674,000 |
| Finished Goods | $39,673,000 | $26,710,000 | $23,150,000 | $13,633,000 |
| Work In Process | $8,514,000 | $8,168,000 | $5,722,000 | $5,499,000 |
| Raw Materials | $10,238,000 | $9,705,000 | $9,766,000 | $6,703,000 |
| Other Short Term Investments | $34,386,000 | $86,335,000 | $37,688,000 | $125,159,000 |
| Investments And Advances | - | $0 | $11,703,000 | $13,902,000 |
| Available For Sale Securities | - | - | $11,703,000 | $13,902,000 |
| Current Provisions | - | - | - | $5,706,000 |
| Line Of Credit | - | - | - | - |
Fetched: 2026-06-11
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-40,050,000 | $-7,669,000 | $-3,594,000 | $17,607,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-34,230,000 | $15,725,000 | $14,594,000 | $35,715,000 |
| Cash Flow From Continuing Operating Activities | $-34,230,000 | $15,725,000 | $14,594,000 | $35,715,000 |
| Operating Gains Losses | $-1,633,000 | $1,720,000 | $-883,000 | $118,000 |
| Investing Activities | ||||
| Capital Expenditure | $-5,820,000 | $-23,394,000 | $-18,188,000 | $-18,108,000 |
| Investing Cash Flow | $46,339,000 | $-59,217,000 | $74,347,000 | $-156,376,000 |
| Cash Flow From Continuing Investing Activities | $46,339,000 | $-59,217,000 | $74,347,000 | $-156,376,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-7,981,000 | $-1,505,000 | $-2,097,000 | $0 |
| Issuance Of Capital Stock | $3,000 | $2,000 | $1,000 | $1,000 |
| Financing Cash Flow | $-4,555,000 | $5,724,000 | $7,415,000 | $8,297,000 |
| Cash Flow From Continuing Financing Activities | $-4,555,000 | $5,724,000 | $7,415,000 | $8,297,000 |
| Net Common Stock Issuance | $-7,978,000 | $-1,503,000 | $-2,096,000 | $1,000 |
| Common Stock Issuance | $3,000 | $2,000 | $1,000 | $1,000 |
| Net Other Financing Charges | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-42,000 | $-165,000 | $-161,000 | $-126,000 |
| Interest Paid Supplemental Data | $122,000 | $87,000 | $75,000 | $52,000 |
| End Cash Position | $153,150,000 | $144,159,000 | $183,038,000 | $86,480,000 |
| Beginning Cash Position | $144,159,000 | $183,038,000 | $86,480,000 | $199,706,000 |
| Effect Of Exchange Rate Changes | $1,437,000 | $-1,111,000 | $202,000 | $-862,000 |
| Changes In Cash | $7,554,000 | $-37,768,000 | $96,356,000 | $-112,364,000 |
| Proceeds From Stock Option Exercised | $3,465,000 | $7,392,000 | $9,672,000 | $8,422,000 |
| Common Stock Payments | $-7,981,000 | $-1,505,000 | $-2,097,000 | $0 |
| Net Issuance Payments Of Debt | $-42,000 | $-165,000 | $-161,000 | $-126,000 |
| Net Long Term Debt Issuance | $-42,000 | $-165,000 | $-161,000 | $-126,000 |
| Long Term Debt Payments | $-42,000 | $-165,000 | $-161,000 | $-126,000 |
| Net Investment Purchase And Sale | $52,159,000 | $-35,823,000 | $92,535,000 | $-138,268,000 |
| Sale Of Investment | $127,522,000 | $44,417,000 | $144,848,000 | $17,480,000 |
| Purchase Of Investment | $-75,363,000 | $-80,240,000 | $-52,313,000 | $-155,748,000 |
| Net PPE Purchase And Sale | $-5,820,000 | $-23,394,000 | $-18,188,000 | $-18,108,000 |
| Purchase Of PPE | $-5,820,000 | $-23,394,000 | $-18,188,000 | $-18,108,000 |
| Change In Working Capital | $-16,327,000 | $-8,964,000 | $-44,095,000 | $-28,879,000 |
| Change In Other Current Liabilities | $-4,557,000 | $-169,000 | $7,140,000 | $-591,000 |
| Change In Other Current Assets | $-15,764,000 | $-13,357,000 | $-2,406,000 | - |
| Change In Payables And Accrued Expense | $-5,507,000 | $75,000 | $-701,000 | $1,805,000 |
| Change In Payable | $-5,507,000 | $75,000 | $-701,000 | $1,805,000 |
| Change In Account Payable | $-5,507,000 | $75,000 | $-701,000 | $1,805,000 |
| Change In Prepaid Assets | $-1,352,000 | $-2,006,000 | $-1,007,000 | $-2,549,000 |
| Change In Inventory | $-16,981,000 | $-10,000,000 | $-14,361,000 | $-7,943,000 |
| Change In Receivables | $27,834,000 | $16,493,000 | $-32,760,000 | $-19,601,000 |
| Changes In Account Receivables | $27,834,000 | $16,493,000 | $-32,760,000 | $-19,601,000 |
| Other Non Cash Items | $3,574,000 | $3,509,000 | $3,154,000 | $47,000 |
| Stock Based Compensation | $30,588,000 | $27,210,000 | $23,516,000 | $20,371,000 |
| Provisionand Write Offof Assets | $8,998,000 | $3,068,000 | $5,514,000 | $3,336,000 |
| Asset Impairment Charge | $15,404,000 | $0 | $154,000 | $0 |
| Amortization Of Securities | $-198,000 | $-1,091,000 | $-2,501,000 | $-1,198,000 |
| Deferred Tax | $-2,916,000 | $3,590,000 | $3,264,000 | $-2,254,000 |
| Deferred Income Tax | $-2,916,000 | $3,590,000 | $3,264,000 | $-2,254,000 |
| Depreciation Amortization Depletion | $8,728,000 | $6,891,000 | $5,124,000 | $4,509,000 |
| Depreciation And Amortization | $8,728,000 | $6,891,000 | $5,124,000 | $4,509,000 |
| Amortization Cash Flow | $409,000 | $0 | $13,000 | $28,000 |
| Amortization Of Intangibles | $409,000 | $0 | $13,000 | $28,000 |
| Depreciation | $8,319,000 | $6,891,000 | $5,111,000 | $4,481,000 |
| Pension And Employee Benefit Expense | $-249,000 | $26,000 | $-956,000 | $53,000 |
| Gain Loss On Sale Of PPE | $-1,384,000 | $1,694,000 | $73,000 | $65,000 |
| Net Income From Continuing Operations | $-80,448,000 | $-20,208,000 | $21,347,000 | $39,665,000 |
| Income Tax Paid Supplemental Data | - | $10,978,000 | $2,844,000 | $6,633,000 |
| Net Short Term Debt Issuance | - | - | $0 | $0 |
| Short Term Debt Payments | - | - | $0 | $0 |
| Net Intangibles Purchase And Sale | - | - | - | - |
| Purchase Of Intangibles | - | - | - | - |
Fetched: 2026-06-11